Abstract
Anti-angiogenic drugs such as bevacizumab can effectively alleviate the patients′ brain edema and clinical symptoms and improve the patients′ life quality by reducing vascular permeability and the blood-brain barrier damage. Bevacizumab has got positive efficacy in the clinical, so that it is considered as an effective and safe treatment for malignant brain edema. Key words: Vascular endothelial growth factors; Brain edema; Brain neoplasms; Bevacizumab
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
